{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:17:58Z","timestamp":1789697878630,"version":"4.0.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The primary objective was to determine whether consolidation (CONS) with 2 short chemotherapy cycles using cytarabine plus idarubicin and high dose cytarabine plus mitoxantrone (2-cycle) reduced the cumulative incidence of relapse compared with the standard regimen of a 6-week CONS phase among newly diagnosed pediatric patients with acute myeloid leukemia (AML).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>GATLA 8-LMA-P\u201907 was a phase 3 trial conducted in 26 centers in Argentina. We included newly diagnosed pediatric patients with AML 0 to 18 years of age. Patients with M3 AML were excluded. After 2 cycles of induction, patients in remission were randomized to either CONS or 2-cycle CONS chemotherapy. High-risk patients received matched family stem cell transplantation or maintenance therapy for 12 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred seven patients younger than 18 years with de novo AML were randomized to CONS (n = 52) or 2-cycle (n = 57). Cumulative incidence (SE) of relapse was not significantly different between CONS (31% [0.1]) and 2-cycle (39% [0.1]) CONS (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.25). There was no significant difference in 5-year event-free survival (53.6% [0.8] vs 44.3 [0.7], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.31) or 5-year overall survival (55.0% [0.8] vs 53.7% [0.7], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.91) for CONS and 2-cycle CONS respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>CONS with 2 cycles of chemotherapy was not significantly better than the standard CONS in reducing the cumulative risk of relapse among newly diagnosed children with AML from Argentina. Future research should evaluate new approaches to improve outcomes for pediatric patients with AML.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000003028","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:01:14Z","timestamp":1747245674000},"page":"250-256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia: Results of the Randomized GATLA 8-LMA-P\u201907 Trial"],"prefix":"10.1097","volume":"47","author":[{"given":"Alejandra","family":"Deana","sequence":"first","affiliation":[{"name":"Hospital Nacional Profesor Alejandro Posadas, El Palomar Moron"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6198-9778","authenticated-orcid":false,"given":"Sergio M.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Hematology and Trasnfusional Medicine Calle, La Plata, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcira Beatriz","family":"Fynn","sequence":"additional","affiliation":[{"name":"Hospital Sor Maria Ludovica, La Plata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-4133","authenticated-orcid":false,"given":"Daniel","family":"Freigeiro","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Gutierrez, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cecilia","family":"Riccheri","sequence":"additional","affiliation":[{"name":"Hospital Nacional Profesor Alejandro Posadas, El Palomar Moron"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Elizabeth","family":"Moran","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Gutierrez, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Leonor","family":"Makiya","sequence":"additional","affiliation":[{"name":"Hospital Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Sung","sequence":"additional","affiliation":[{"name":"Sick Kids: The Hospital for Sick Kids, Toronto, Canada"},{"name":"Division of Haematology\/Oncology Chief Clinical Data Scientist, The Hospital for Sick Children University Avenue, Canada Research Chair in Pediatric Oncology Supportive Care, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"R1-20250623","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41375-018-0071-7","article-title":"Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012","volume":"32","author":"Rasche","year":"2018","journal-title":"Leukemia"},{"key":"R2-20250623","doi-asserted-by":"crossref","first-page":"e1849","DOI":"10.1002\/cnr2.1849","article-title":"Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline","volume":"6","author":"van Weelderen","year":"2023","journal-title":"Cancer Rep"},{"key":"R3-20250623","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative efforts driving progress in pediatric acute myeloid leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J Clin Oncol"},{"key":"R4-20250623","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1182\/blood-2013-01-476614","article-title":"Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children\u2019s Oncology Group","volume":"121","author":"Sung","year":"2013","journal-title":"Blood"},{"key":"R5-20250623","first-page":"e152","article-title":"Pediatric cancer registries in Latin America: the case of Argentina\u2019s pediatric cancer registry","volume":"41","author":"Fedorovsky","year":"2017","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"key":"R6-20250623","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2011.08851.x","article-title":"Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial","volume":"155","author":"Gibson","year":"2011","journal-title":"Br J Haematol"},{"key":"R7-20250623","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2013-02-484097","article-title":"Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: Results from study AML-BFM 2004","volume":"122","author":"Creutzig","year":"2013","journal-title":"Blood"},{"key":"R8-20250623","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline Dose Intensification in Acute Myeloid Leukemia","volume":"361","author":"Fernandez","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"R9-20250623","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1200\/JCO.2006.06.5037","article-title":"Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 98","volume":"24","author":"Creutzig","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"R10-20250623","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002770050162","article-title":"Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis","volume":"72","author":"Amadori","year":"1996","journal-title":"Ann Hematol"},{"key":"R11-20250623","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"R12-20250623","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-103-3-460","article-title":"Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7)","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"R13-20250623","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.14411","article-title":"Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy","volume":"176","author":"Frishman-Levy","year":"2017","journal-title":"Br J Haematol"},{"key":"R14-20250623","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.1999.01304.x","article-title":"Definition of a standard-risk group in children with AML","volume":"104","author":"Creutzig","year":"1999","journal-title":"Br J Haematol"},{"key":"R15-20250623","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1200\/JCO.2001.19.10.2705","article-title":"Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study acute myeloid Leukemia-Berlin-Frankfurt-M\u00fcnster 93","volume":"19","author":"Creutzig","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"R16-20250623","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative incidence functions in competing risks studies","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"},{"key":"R17-20250623","article-title":"The Kaplan Meier estimate in survival analysis","volume":"5","author":"Etikan","year":"2017","journal-title":"Biom Biostat Int J"},{"key":"R18-20250623","article-title":"R Studio","author":"Martin","year":"2021","journal-title":"In: An Introduction to Programming with R"},{"key":"R19-20250623","doi-asserted-by":"crossref","first-page":"e29281","DOI":"10.1002\/pbc.29281","article-title":"Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: a report from the Children\u2019s Oncology Group","volume":"68","author":"Elgarten","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R20-20250623","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/sj.leu.2403854","article-title":"Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials","volume":"19","author":"Armendariz","year":"2005","journal-title":"Leukemia"},{"key":"R21-20250623","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.7314\/APJCP.2012.13.12.6491","article-title":"Socio-economic status plays important roles in childhood cancer treatment outcome in Indonesia","volume":"13","author":"Mostert","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"R22-20250623","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26879","article-title":"A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: the Pediatric Oncology in Develop- ing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)","author":"Howard","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20250623","doi-asserted-by":"crossref","first-page":"e28087","DOI":"10.1002\/pbc.28087","article-title":"SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings","volume":"70","author":"Bansal","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20250623","doi-asserted-by":"crossref","first-page":"e28979","DOI":"10.1002\/pbc.28979","article-title":"Treatment of acute myeloid leukemia in children: a practical perspective","volume":"68","author":"Egan","year":"2021","journal-title":"Pediatric Blood and Cancer"},{"key":"R25-20250623","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4274\/iksstd.2021.49389","article-title":"Evaluation of acute toxicity and survival in children with acute myeloid leukemia treatment: a single-center retrospective study from a middle-income country","volume":"13","author":"Ay\u00e7i\u00e7ek","year":"2021","journal-title":"\u0130stanbul Kanuni Sultan S\u00fcleyman Tip Dergisi"},{"key":"R26-20250623","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00431-017-2978-9","article-title":"Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience","volume":"176","author":"Kairiene","year":"2017","journal-title":"Eur J Pediatr"},{"key":"R27-20250623","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clml.2018.02.002","article-title":"Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center","volume":"18","author":"Jaime-P\u00e9rez","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R28-20250623","doi-asserted-by":"crossref","first-page":"e43639","DOI":"10.1371\/journal.pone.0043639","article-title":"Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El salvador","volume":"7","author":"Gavidia","year":"2012","journal-title":"PLoS One"},{"key":"R29-20250623","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12288-015-0591-5","article-title":"Acute Myeloid Leukemia in Children: Experience from Tertiary Cancer Centre in India","volume":"32","author":"Radhakrishnan","year":"2016","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"key":"R30-20250623","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12887-020-02408-y","article-title":"Leukemia mortality in children from Latin America: trends and predictions to 2030","volume":"20","author":"Torres-Roman","year":"2020","journal-title":"BMC Pediatr"},{"key":"R31-20250623","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/pbc.20989","article-title":"Protocol-based treatment for children with cancer in low income countries in Latin America a report on the recent meetings of the Monza International School of Pediatric Hematology\/Oncology (MISPHO) - PART II. In","volume":"48","author":"Howard","year":"2007","journal-title":"Pediatric Blood and Cancer"},{"issue":"suppl_15)","key":"R32-20250623","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1200\/JCO.2019.37.15_suppl.10002","article-title":"Effect of intensification of induction II chemotherapy and liberalization of stem cell donor source on outcome for children with high risk acute myeloid leukemia: a report from the Children\u2019s Oncology Group","volume":"37","author":"Aplenc","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"R33-20250623","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.2003.04418.x","article-title":"Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down\u2019s syndrome: Results of NOPHO-AML trials","volume":"122","author":"Lie","year":"2003","journal-title":"Br J Haematol"},{"key":"R34-20250623","first-page":"2275","article-title":"Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023","volume":"108","author":"Egan","year":"2023","journal-title":"Haematologica"},{"key":"R35-20250623","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3324\/haematol.2019.220962","article-title":"Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children\u2019s Oncology Group","volume":"105","author":"Aplenc","year":"2020","journal-title":"Haematologica"},{"key":"R36-20250623","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO.2014.55.3628","article-title":"Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: Results from the randomized phase iII children\u2019s oncology group Trial AAML0531","volume":"32","author":"Gamis","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"R37-20250623","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1200\/JCO.19.00327","article-title":"Clofarabine can replace anthracyclines and etoposide in remission induction therapy for childhood acute myeloid leukemia: the AML08 multicenter, randomized phase III trial","volume":"37","author":"Rubnitz","year":"2019","journal-title":"Journal of Clinical Oncology"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:21Z","timestamp":1750690821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003028","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"2024-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}